alpha7 nicotinic receptor radiotracers (Helmholtz-Zentrum Dresden-Rossendorf)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namealpha7 nicotinic receptor radiotracers (Helmholtz-Zentrum Dresden-Rossendorf)
Drug Alias Name18F-DBT-10
ClassificationRadiation-emitting products
Mechanisms of ActionNeuronal acetylcholine receptor protein alpha-7 subunit modulators
TargetsNeuronal acetylcholine receptor protein alpha-7 subunit
Therapy Area/IndicationsCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHelmholtz-Zentrum Dresden-Rossendorf
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHelmholtz-Zentrum Dresden-Rossendorf
Active IndicationsN/A
Inactive IndicationsCentral Nervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A